Between Science and Teaching
My Professional Journey
"I am Professor Alfonso Baldi, an anatomic pathologist with over 20 years of experience in the field of histopathological research and diagnosis. My career has been dedicated to advancing medical sciences through research, academic teaching, and collaboration with national and international institutions."
WhO I Am
Professional Training
I earned my Medical Degree with honors in 1992 and subsequently completed my Residency in Anatomic Pathology with honors in 1996.
I am currently Associate Professor of Anatomic Pathology at the Department of Life, Health and Health Professions Sciences of Link Campus University, Rome. Additionally, I hold the National Scientific Qualification for Full Professor in Anatomic Pathology MED/08 (Call 2018).
From 2001 to 2024, I held the position of University Researcher and later Associate Professor of Anatomic Pathology at the University of Campania “L. Vanvitelli.”
I am currently Associate Professor of Anatomic Pathology at the Department of Life, Health and Health Professions Sciences of Link Campus University, Rome. Additionally, I hold the National Scientific Qualification for Full Professor in Anatomic Pathology MED/08 (Call 2018).
SIGNIFICANT SCIENTIFIC CONTRIBUTIONS
During my research activity abroad at Temple University and Thomas Jefferson University in Philadelphia, I made a fundamental contribution to the identification of the tumor suppressor gene Rb2/p130, its chromosomal localization in humans, and the characterization of its genomic structure. Additionally, I produced innovative observations on the role of cell cycle regulatory proteins in tumor progression.
In collaboration with Campus Bio-Medico University of Rome and the Istituto dei Tumori of Rome, I characterized the molecular pathways involved in melanoma progression, with a particular focus on the serine protease HtrA1. Moreover, my studies generated original data on the role of apoptosis in post-infarction ventricular remodeling.
At the University of Campania “L. Vanvitelli”, I conducted pioneering studies on the effects of electrochemotherapy in animal models. These investigations led to the establishment of an industrial spin-off, resulting in the development of the Onkodisruptor® electroporator, an advanced device for veterinary electrochemotherapy and other technological applications, such as DNA vaccination and nanovesicle loading.
Focus on EndometriOsis
In collaboration with the Italian Endometriosis Foundation, I have generated pivotal data to improve the understanding of the pathogenesis of endometriosis and to enhance early diagnosis of the disease, developing both in vitro and in vivo models of substantial scientific relevance.
Institutional Roles and CollaboratiOns
Among the institutional positions I have held:
- Founding Member and Scientific Director of Fondazione FUTURA-onlus, dedicated to biomedical research
- Scientific Director of the Italian Endometriosis Foundation, focused on translational research in endometriotic disease
- Member of the Scientific Committee of the Italian League for the Fight Against Cancer (LILT), Rome Provincial Section
- Associate Researcher at the Institute of Biosciences and Bioresources (CNR), Naples
- Director of the "Orchidealab" Anatomic Pathology Laboratory, Rome
- Director of the Translational Pathology Laboratory at CEINGE, Naples (2014–2018)
- Adjunct Professor at Temple University, Philadelphia, PA, USA (until June 2016)
- Co-founder and Scientific Director of Biopulse S.r.l., a company focused on the development and production of electromedical devices
